8-K: BRC Inc. Faces NYSE Delisting Warning Over Share Price

BRC Inc. received a notice from the NYSE for failing to meet the minimum average closing price requirement of $1.00 per share, triggering a six-month cure period.

Summary

• BRC Inc. (BRCC) received a notice from the New York Stock Exchange (NYSE) on February 11, 2026, indicating non-compliance with Section 802.01C.
• The non-compliance is due to the average closing price of its Class A Common Stock being below $1.00 per share over a consecutive 30 trading-day period ended February 11, 2026.
• The notice does not immediately affect the listing or trading of the Common Stock on the NYSE.
• The Company has a six-month period from the notice date to regain compliance.
• Compliance can be regained if, on the last trading day of any calendar month during the cure period, the stock has a closing price of at least $1.00 and an average closing price of at least $1.00 over the prior 30 trading days.
• BRC Inc. intends to notify the NYSE within ten business days of receipt of the notice that it plans to cure the deficiency.
• The Company is evaluating alternatives to regain compliance and expects to pursue those in the best interest of the Company and its shareholders.
• The notice does not impact the Company's business operations, financial condition, or SEC reporting obligations.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a negative development, as the delisting notice highlights significant underperformance in share price. While the company has a cure period, the underlying issues leading to this price decline are concerning for investors.

Positives

• The notice does not have any immediate effect on the listing of the Common Stock on the NYSE.
• The Company has a six-month cure period to regain compliance.
• The notice does not affect the Company's business operations, financial condition, or SEC reporting obligations.
• Management intends to notify the NYSE of its plan to cure the deficiency and is evaluating alternatives.

Negatives

• BRC Inc.'s Class A Common Stock traded below an average closing price of $1.00 per share for 30 consecutive trading days.
• The Company is not in compliance with a key NYSE continued listing standard (Section 802.01C).
• Failure to regain compliance within six months could lead to delisting from the NYSE.

Risks

• Reactions from employees, vendors, customers, lenders, and investors to the notice.
• Inability to regain compliance with the NYSE minimum share price requirement within the six-month cure period.
• Inability to continue to comply with other NYSE listing standards after regaining compliance.
• The impact of the Company's process to explore available alternatives to regain compliance and the outcome of such process.
• The possibility that the NYSE may delist the Common Stock.
• Other risks and uncertainties detailed in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2024.

Future Outlook

BRC Inc. plans to notify the NYSE within ten business days of receiving the notice that it intends to cure the deficiency. The Company is actively evaluating various alternatives to regain compliance with the minimum share price requirement and expects to pursue options that best serve the interests of the Company and its shareholders.

Management Comments

• "The Company intends to notify the NYSE within ten business days of receipt of the Notice that it plans to cure the deficiency."
• "The Company is evaluating available alternatives to regain compliance with the minimum share price requirement and expects to pursue those alternatives that are in the best interest of the Company and its shareholders."

Industry Context

StockSavvy.ai notes that receiving a delisting notice due to low share price is a significant event for any publicly traded company, often signaling underlying operational or market challenges. While BRC Inc. has a six-month period to regain compliance, this situation can erode investor confidence and potentially impact the company's ability to raise capital or conduct business effectively, especially when compared to peers maintaining stable listing status.

Stakeholder Impact

• Shareholders: Potential for further stock price volatility, risk of delisting, and uncertainty regarding the company's future market valuation.
• Employees: Potential impact on morale and perception of company stability.
• Vendors/Customers/Lenders: Possible concerns regarding the company's financial health and stability, potentially affecting terms of business or credit.

Next Steps

• BRC Inc. to notify the NYSE within ten business days of February 11, 2026, of its plan to cure the deficiency.
• BRC Inc. to evaluate and pursue alternatives to regain compliance with the minimum share price requirement.
• Regain compliance within the six-month cure period (by approximately August 11, 2026).

Key Dates

Recommendation

While the delisting notice is a significant negative signal, the company has a clear path and stated intent to regain compliance within the six-month cure period. A seasoned investor would likely 'hold' to observe management's actions and the effectiveness of their plan to address the share price deficiency, rather than immediately selling into potential panic. However, this 'hold' comes with increased risk and requires close monitoring of the stock's performance and company announcements regarding their compliance efforts.

Keywords

BRC Inc., BRCC, NYSE, Delisting Notice, Share Price Compliance, Minimum Price Rule, Stock Exchange, Corporate Governance, Investment Risk, Publicly Traded